The visible symptoms only scratch the surface of this chronic skin condition Living with a chronic condition like atopic ...

When my mind is struggling but I’m pretending I’m fine, my skin tells the truth My eczema doesn’t just show up on my skin—it ...

Lilly’s recently-launched direct-to-consumer campaign also embraces a digital-first approach to reach eczema patients.

Reaction severity and skin prick testing results predicted persistent sesame allergy among children, according to a study published in Pediatric Allergy and Immunology. These risk factors can help ...

Benefits advisors need to stay proactive and help their clients leverage formulary design, clinical oversight, and ...

(HKEX: 02162)�("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed�IL-4Ra ...

"Winning a fourth Top Workplaces USA Award is a testament to our exceptional Castle team and people-first culture," said Derek Maetzold, president and chief executive officer of Castle Biosciences.

No association was observed between serious infection risk and Janus kinase inhibitor use in patients with immune-mediated inflammatory skin disease.

Panelists discuss how the 18-month retrospective claims analysis of ruxolitinib revealed sustained efficacy in atopic dermatitis management, with significant reductions in disease flares, healthcare ...

Following the launch of the first disease-modifying therapies for Alzheimer’s disease, a key theme at the AD/PD 2025 ...

Johnson & Johnson has reported positive results from a Phase IIIb trial of Tremfya (guselkumab) for active psoriatic ...

Patients with suspected eyelid allergic contact dermatitis can benefit from patch testing beyond common allergens.